A Multimodal Treatment Strategy to Manage Severe Cutaneous Mpox
A 33-year-old bisexual man with advanced HIV and severe mpox developed severe cutaneous disease despite receiving tecovirimat, antiretroviral therapy, and vaccinia immune globulin. His condition improved after he received topical, intralesional, and intravenous cidofovir and debridement of his mpox...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-12-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|